Conservatives speak out against 'binding arbitration' for drug prices

8 May 2019
congress_senate_house_hearing_committee_enquiry_big

Right-wing think tank The Institute for Policy Innovation (IPI) has commented on the ongoing US  Congressional debate over “Medicare for all” proposals, condemning the idea as imposing: “socialist price controls on Medicare's prescription drugs.”

The IPI, which is funded by conservative activists Charles and David Koch, as well as corporations and conservative foundations, is concerned that a related idea called “binding arbitration” could now gain support in Congress.

The group says the proposal would be just as damaging as Medicare for all, and “would allow government-appointed arbitrators to dictate” prescription drug prices.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Today's issue

Company Spotlight





More Features in Pharmaceutical